UCALNSEUCAL LIMITEDHighNeutral
Announced Wed, 27 May · 17:43 IST

UCAL LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat NegativeEbitda Margin CompressionExceptional ItemResults View source PDF

UCAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.8%1-day move
₹96.80
prior close
₹97.83
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+1.2+3.5+2.0+1.8+2.3+0.2+0.3+0.3+2.7+10.2+25.6
Up moveDown movePending
AI summary

UCAL Limited reported standalone revenue of Rs 61,664.34 Lakhs for FY26, up 5.8% from Rs 58,279.83 Lakhs in FY25. However, the company swung to a massive standalone net loss of Rs 9,676.68 Lakhs compared to a profit of Rs 2,260.38 Lakhs in FY25. This was primarily due to an exceptional item of Rs 10,368.27 Lakhs representing a write-down in the carrying value of investments in UCAL Holdings Inc., USA, after the company's controlling stake was diluted from 100% to 10% on March 15, 2026. Consolidated revenue grew to Rs 83,782.06 Lakhs but consolidated net loss widened to Rs 3,332.32 Lakhs from Rs 1,628 Lakhs in FY25. The auditors issued an unmodified opinion on both standalone and consolidated results. EBITDA margin compression is evident from the decline in operating profitability excluding exceptional items.

Likely market impact

The exceptional write-down of Rs 10,368.27 Lakhs has severely impacted bottom-line, turning standalone PAT negative. The stock may face pressure due to the large loss, though the core automotive components business continues to generate revenue growth. The dilution of the US subsidiary reduces group complexity.